Shockwave Medical
Shockwave Medical raises $150M Convertible Note at $5B valuation
Quick Facts
Shockwave Medical: Convertible Note Funding Round
Shockwave Medical has successfully raised $150M in Convertible Note funding, reaching a valuation of $5B.
Company Overview
Intravascular lithotripsy system
Funding Details
The Convertible Note round was led by Aisling Capital, with participation from Valiance Life Sciences, EW Healthcare Partners, Longitude Capital.
Company Information
- Headquarters: 5403 Betsy Ross Drive, Santa Clara, CA 95054
- Founded: 2009
- Employees: 600+
- Category: MedTech
Investment
Shockwave Medical plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Aisling Capital: Verified investor in Convertible Note
- Valiance Life Sciences: Verified investor in Convertible Note
- EW Healthcare Partners: Verified investor in Convertible Note
- Longitude Capital: Verified investor in Convertible Note
Key Investors
About the Author
Related Company Reports
NeuroLink Brain Raises $580M Series D to Transform Healthcare
NeuroLink Brain secures $580M in Series D funding at $8.2B valuation to complete fda approval process, scale manufacturing for clinical deployment, and expand treatment applications.
MedTech Revolution Secures $890M Series D to Lead MedTech Innovation
MedTech Revolution raises $890M in Series D funding at $13.7B valuation to complete clinical trials for 5 medical devices, scale robotic surgery systems, and expand to asian markets.
ForSight Robotics raises $125M Series B at $700M valuation
ForSight Robotics raises $125M in Series B at $700M valuation. Ophthalmic surgical robots...